Imaging Blood Brain Imaging Dysfunction in Parkinson's Disease
NCT02605161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17
Last updated 2020-12-31
Summary
The purpose of this study is to evaluate the blood brain barrier in the striatum of patients that have other types of movement disorders compared to patients with Parkinson's Disease that are receiving similar treatment, to determine if a there is a disruption of the blood brain barrier in patients with Parkinson's Disease.
Conditions
Sponsors & Collaborators
-
Ottawa Hospital Research Institute
lead OTHER
Principal Investigators
-
Thanh B Nguyen, MD, FRCP · The Ottawa Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2020-09-08
- Completion
- 2020-09-08
Countries
- Canada
Study Locations
More Related Trials
-
Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions
NCT00970333 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NCT01028209 ·Status: TERMINATED ·Phase: PHASE1
-
Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease
NCT01696708 ·Status: COMPLETED ·Phase: NA
-
Neuromelanin MRI: A Progression Marker in Early PD
NCT05631158 ·Status: UNKNOWN
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
The GBA Multimodal Study in Parkinson's Disease
NCT04101968 ·Status: RECRUITING
-
Brain Imaging Study of Brain Plasticity in Chronic Stroke Patients
NCT03392519 ·Status: COMPLETED
-
Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II
NCT02317250 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study of New Magnetic Resonance Imaging Methods of the Brain
NCT00004577 ·Status: RECRUITING
-
A Study of Imaging in Demyelinating Diseases
NCT05805839 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)
NCT06289582 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)
NCT03702816 ·Status: TERMINATED ·Phase: PHASE2
-
Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease
NCT00249080 ·Status: COMPLETED
-
Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias
NCT02945774 ·Status: RECRUITING ·Phase: NA
-
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
NCT02649985 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621 ·Status: COMPLETED
-
Diagnosis Of Vertigo With New Imaging
NCT00593216 ·Status: COMPLETED
-
Establishing 18F-PBR06 PET Imaging as a Viable Pharmacodynamic Endpoint in MSA
NCT03033680 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis
NCT00547976 ·Status: COMPLETED ·Phase: PHASE1
-
Multimodal Retinal Imaging in the Detection and Follow-up of Alzheimer's Disease
NCT03466177 ·Status: RECRUITING
-
Study of Structural Imaging
NCT02564991 ·Status: COMPLETED
-
Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study
NCT05753995 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
NCT06965816 ·Status: COMPLETED
-
Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke
NCT02767999 ·Status: COMPLETED ·Phase: PHASE4
-
Rapid MRI for Assessing Functional Abilities and Predicting TBI Outcomes
NCT06454591 ·Status: RECRUITING